Adam H Schechter Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 1 hour ago
Adam H Schechter has an estimated net worth of at least $47.3 million*, as of Aug. 12, 2026. They own 102,565 shares of LH stock. They have sold 54,353 shares of LH stock since 2021, for an estimated $13.0 million.
Adam H Schechter $LH SEC Form 4 Insider Trading
Adam H Schechter has filed a total of 9 insider trades in $LH since 2021. Their most recent trade was a sale of 4,669 shares, made on Aug 11, 2026. Their largest trade was a sale of 8,705 shares, made on Mar 03, 2026. We estimate that they now own 102,565 shares of $LH, worth an estimated $34.3 million.
Insider Trading at $LH
There have been a total of 119 insider trades reported at $LH since 2021, with 3,586 shares purchased and 315,990 shares sold. The most active insider traders in $LH stock have been Der Vaart Sandra D Van, Glenn A Eisenberg, and Peter J Wilkinson. The most recent trade was a sale of 3,000 shares reported by KERRII B ANDERSON (None), made on Aug 17, 2026.
History of Insider Stock Trades by Adam H Schechter
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
LH
|
Sale | 4,669 | Aug 11, 2026 | Aug. 12, 2026, 2:31 p.m. |
|
LH
|
Sale | 5,903 | May 11, 2026 | May 13, 2026, 9:30 a.m. |
|
LH
|
Sale | 8,705 | Mar 03, 2026 | March 5, 2026, 9:57 a.m. |
|
LH
|
Sale | 5,273 | Feb 11, 2026 | Feb. 13, 2026, 2:13 p.m. |
|
LH
|
Sale | 5,745 | Nov 11, 2025 | Nov. 13, 2025, 9:47 a.m. |
|
LH
|
Sale | 5,643 | Aug 11, 2025 | Aug. 13, 2025, 12:29 p.m. |
|
LH
|
Sale | 6,105 | May 12, 2025 | May 13, 2025, 10:01 a.m. |
|
LH
|
Sale | 6,121 | Feb 11, 2025 | Feb. 13, 2025, 12:49 p.m. |
|
LH
|
Sale | 6,189 | Nov 11, 2024 | Nov. 13, 2024, 9:16 a.m. |
$LH Executives and Stock Owners with Insider Trades
-
Der Vaart Sandra D Van, EVP, Chief Legal Officer
-
Glenn A Eisenberg, Chief Financial Officer, EVP
-
Peter J Wilkinson, SVP, Chief Accounting Officer
-
Adam H Schechter, President & CEO
-
Mark S Schroeder, EVP, President-Diagnostics Lab
-
Amy B. Summy, EVP, Chief Marketing Officer
-
Mark S Schroeder, EVP, Pres Diagnostics & COO
-
Jonathan C Meltzer, EVP, Operations
-
Paul R Kirchgraber, CEO, Covance Drug Development
-
Brian J Caveney, EVP, Pres of ED, CMO & CSO
-
Brian J Caveney, EVP, President of Diagnostics
-
Kathryn W Kyle, EVP, Chief Legal Officer
-
Lance Berberian, EVP, CIO & CTO
-
Jonathan P. Divincenzo, EVP, Pres, Central Labs & Intl
-
Glenn A Eisenberg, Executive Vice President
-
Bryan T Vaughn, EVP and President, Diagnostics
-
Der Vaart Sandra D Van, EVP, Corporate Affairs
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.